The potential therapy for idiopathic pulmonary fibrosis is notable because not only was the small molecule discovered by ...

For children with severe Crohn disease, upadacitinib offers an effective induction therapy, but its benefits must be ...

Our knowledge of the effects of space and low gravity on blood cells, clotting, and anemia continues to expand, but further ...

The phase 3 IRAKLIA trial assesses subcutaneous isatuximab via on-body injector vs intravenous (IV) administration, in combination with pomalidomide and dexamethasone, in relapsed/refractory multiple ...

While the tax exclusion for employer-sponsored health care was not included in the House-passed reconciliation bill, it ...

Cemiplimab improved disease-free survival in patients with high-risk cutaneous squamous cell carcinoma (CSCC) and performed ...

A new analysis of obesity guidelines suggests more evidence is needed to develop stronger guidelines for the transition ...

Real-world data show no significant differences in overall survival between patients with or without cytogenetic risk factors ...

Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth ...

A combination of acalabrutinib and venetoclax showed better results with the addition of obinutuzumab, whereas mixed findings ...

The findings support the clinical benefits of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) ...

Patients with relapsed/refractory (R/R) multiple myeloma and lower socioeconomic status reported significantly worse quality of life and a higher burden of symptoms, according to Francesco Sparano, ...